Latest Aortic dissection Stories
ATLANTA, April 25, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011.
DETROIT, April 3, 2011 /PRNewswire/ -- A major new study presented today at the yearly scientific meeting of the American College of Cardiology (ACC) in New Orleans shows conclusively that replacing defective aortic valves in elderly patients through non-invasive "catheterization" - rather than through much more invasive open-heart surgery - leads to significantly better outcomes. The new clinical trial study (PARTNER cohort A: Transcatheter valves noninferior to surgery), documents important...
ANN ARBOR, Mich., March 11, 2011 /PRNewswire-USNewswire/ -- The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves. The nationally ranked U-M is among 40 sites in the nation selected for the Medtronic CoreValve U.S.
Two patients who had severe aortic stenosis are "recovering well" - only days after the minimally invasive procedure DETROIT, March 1, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has completed the first two transcatheter aortic valve implants (TAVI) ever achieved in Michigan.
MOUNTAIN VIEW, Calif., Dec. 21 2010 /PRNewswire/ -- El Camino Hospital today announced its first patient implant in the Medtronic CoreValveÂ® U.S. Clinical Trial. El Camino Hospital is one of the first of 40 hospitals across the U.S.
Discovery of a fifth gene defect and the identification of 47 DNA regions linked to thoracic aortic disease are the subject of studies released this month involving researchers at The University of Texas Health Science Center at Houston (UTHealth).
Despite the promising results of the "Placement of Aortic Transcatheter Valves (PARTNER) trial," featured in the Oct. 21 issue of the New England Journal of Medicine, a cardiothoracic surgeon from Boston Medical Center (BMC) believes that surgical aortic-valve replacement should remain the standard treatment of aortic stenosis.
ATLANTA, Oct. 7 /PRNewswire/ -- CryoLife, Inc.
One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis.
Implantation of a new bioprosthetic-tissue valve into the hearts of patients who have severe aortic stenosis and are too sick or too old for open-heart surgery has been found to both save lives and improve the quality of those lives.
Aortography is the study of the specific action involving the ejection of blood from the aorta in the heart. Taking an aortogram from the patient could identify if there is a tear in the intimal wall of the aorta. This tear is eventually fatal but can be repaired in some cases. Procedure A catheter is placed in the aorta of the patient, usually through the femoral artery. Once in place a dose of iodine-based dye is injected in order to visualize the flow of blood through the site....
- A person in a secondary role, specifically the second most important character (after the protagonist).